Antonina Germano
Orbassano, 10043, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma.
Journal: Cells
Published: March 10, 2020
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells.
Journal: PloS one
Published: January 16, 2018
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 21, 2017
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer.
Journal: Endocrine-related cancer
Published: March 22, 2017
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization.
Journal: Molecular and cellular endocrinology
Published: August 21, 2014
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines.
Journal: Molecular and cellular endocrinology
Published: April 04, 2013
Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.
Journal: Thyroid : official journal of the American Thyroid Association
Published: March 28, 2013
Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 02, 2012
Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma.
Journal: European journal of endocrinology
Published: December 23, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026